You are here
Paravax Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
CELL CULTURE PRODUCTION OF TOXOPLASMA GONDII TISSUE CYST
Amount: $730,970.00TOXOPLASMA GONDII STRAIN T-263 IS AN OOCYST NEGATIV GENETIC MUTANT THAT INDUCES IMMUNITY IN CATS TO WILD STRAINS WHEN TISSUE CYSTS OR BRADYZOITES ARE ADMINISTERED ORALLY. THE VACCINE POTENTIAL OF T-26 ...
SBIRPhase II1995Department of Health and Human Services -
VACCINE POTENTIAL OF TOXOPLASMA GONDII RECOMBINANT P3
Amount: $500,000.00P30, THE MAJOR SURFACE ANTIGEN OF THE TOXOPLASMA GONDII TACHYZOITE STAGE, HAS BEEN ISOLATED FROM THE PARASITE AND SHOWN TO PROTECT MICE FROM A VIRULENT T. GONDII CHALLENGE. THE CDNA ENCODING P30 HAD B ...
SBIRPhase II1993Department of Health and Human Services -
Lyophilization of a Live Toxoplasma Gondii Vaccine
Amount: $41,593.00Toxoplasma gondii strain T-263 is an oocyst negative genetic mutant that induces immunity to oocyst shedding in cats when tissue cysts or bradyzoites are administered orally. The vaccine potential of ...
SBIRPhase I1993Department of Health and Human Services -
CELL CULTURE PRODUCTION OF TOXOPLASMA GONDII TISSUE CYST
Amount: $50,000.00N/A
SBIRPhase I1992Department of Health and Human Services -
VACCINE POTENTIAL OF TOXOPLASMA GONDII RECOMBINANT P3
Amount: $49,809.00N/A
SBIRPhase I1991Department of Health and Human Services -
IMPROVEMENTS IN TICK CELL LINE CULTURE
Amount: $49,632.00THE SPECIFIC AIM OF THIS PROJECT IS TO IMPROVE THE SURVIVAL AND PROLIFERATIVE ABILITY OF TICK CELL LINES. DRAWING UPON RECENT IMPROVEMENTS IN THE TISSUE CULTURE OF INSECT CELLS THAT HAVE LED TO THE CO ...
SBIRPhase I1989Department of Health and Human Services